H.R. 4764 · 116th Congress

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020

Action history

2020-12-14Message on Senate action sent to the House.
2020-12-11Measure laid before Senate by unanimous consent.
2020-12-11Passed Senate with an amendment by Voice Vote.
2020-10-01Received in the Senate, read twice.
2020-09-30Motion to reconsider laid on the table Agreed to without objection.
2020-09-30On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 414 - 0 (Roll no. 211).
2020-09-30Considered as unfinished business.
2020-09-29At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
2020-09-29DEBATE - The House proceeded with forty minutes of debate on H.R. 4764.
2020-09-29Considered under suspension of the rules.
2020-09-29Mr. Pallone moved to suspend the rules and pass the bill, as amended.
2020-09-29Reported by the Committee on Energy and Commerce. H. Rept. 116-549.
2020-09-29Placed on the Union Calendar, Calendar No. 449.
2020-09-09Committee Consideration and Mark-up Session Held.
2020-09-09Ordered to be Reported by Voice Vote.
2019-10-21Referred to the Subcommittee on Health.
2019-10-18Introduced in House
2019-10-18Referred to the House Committee on Energy and Commerce.